跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 497 条关于
“hATTR-PN”
全部
497
临床试验
251
药物
81
机构
2
资讯
163
10个月前
Royalty Pharma Acquires $310 Million AMVUTTRA Royalty Interest from Blackstone Life Sciences
去年
FDA Accepts Alnylam's Vutrisiran sNDA for ATTR Amyloidosis with Cardiomyopathy
18天前
Alnylam Presents New Data at ESC Congress 2026 Reinforcing RNAi-Powered TTR Silencing in ATTR-CM and Hypertension
7个月前
Alnylam Pharmaceuticals Prepares for Q4 Results with Amvuttra Sales Surge and Pipeline Advances
去年
FDA Accepts Alnylam's Vutrisiran Application for ATTR Amyloidosis with Cardiomyopathy
去年
EU Committee Recommends AstraZeneca and Ionis' Wainzua for ATTRv-PN
2年前
Alnylam's AMVUTTRA Shows Significant Cardiac Benefits in ATTR Amyloidosis Patients at ACC.25
8年前
CHMP Backs Novel Therapies: Onpattro for hATTR and Symkevi for Cystic Fibrosis
去年
Mirdametinib Demonstrates Significant Tumor Reduction and Improved Quality of Life in NF1-Associated Plexiform Neurofibroma
去年
Mirdametinib Shows Deep Responses in NF1-Associated Plexiform Neurofibromas
第 1 页,共 17 页
上一页
下一页